Article
Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population.
Internal medicine journal - 1 May 2015
Larsen P D, Johnston L R, Holley A, La Flamme A C, Smyth L, Chua E W, Kennedy M A, Harding S A
Abstract excerpt
BACKGROUND: High on-treatment platelet reactivity has been associated with poor outcomes following acute coronary syndromes (ACS). Both the loss of function CYP2C19*2 allele and the gain of function CYP2C19*17 allele along with a range of clinical characteristics have been associated with variati...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.